Saturday, October 3, 2026
BTC $84,624 ▼ 2.09%
Subscribe
Menu
NewsLive WirePoliticsWorldMarketsDigital AssetsTechnologySports
FranchisesThe BriefThe Big ReadThe BreakdownCrypto Culture
MoreDeFi & On-ChainU.S. EquitiesMacro & RatesResearch
LIVE
BTC$84,624down−2.09%ETH$2,682down−2.39%SOL$119.31down−2.36%XRP$1.48down−3.69%LINK$13.92down−3.63%ADA$0.245down−4.20%S&P 5007,723up+0.73%Nasdaq27,191up+1.19%Dow51,177up+0.49%RUT2,833up+0.94%TNX5.28%up+0.76%TYX5.63%up+0.48%FVX5.05%up+1.00%IRX3.99%up+0.28%VIX15.31down−6.59%GOLD$4,162.30down−0.95%SILVER$60.42down−1.24%OIL$91.11down−1.90%DXY101.92down−0.01%NVDA$233.95up+1.34%AAPL$333.69up+1.02%TSLA$370.59up+4.65%META$728.08up+0.30%MSFT$517.53up+0.92%AMZN$251.52up+1.33%GOOGL$343.50up+1.56%Fear & Greed67 — GreedBTC$84,624down−2.09%ETH$2,682down−2.39%SOL$119.31down−2.36%XRP$1.48down−3.69%LINK$13.92down−3.63%ADA$0.245down−4.20%S&P 5007,723up+0.73%Nasdaq27,191up+1.19%Dow51,177up+0.49%RUT2,833up+0.94%TNX5.28%up+0.76%TYX5.63%up+0.48%FVX5.05%up+1.00%IRX3.99%up+0.28%VIX15.31down−6.59%GOLD$4,162.30down−0.95%SILVER$60.42down−1.24%OIL$91.11down−1.90%DXY101.92down−0.01%NVDA$233.95up+1.34%AAPL$333.69up+1.02%TSLA$370.59up+4.65%META$728.08up+0.30%MSFT$517.53up+0.92%AMZN$251.52up+1.33%GOOGL$343.50up+1.56%Fear & Greed67 — Greed
Tag

dominion energy

1 article

Regeneron Rises 3.4% on Eye Drug Trial Win; Mobileye Gains on $1.5B Auto Deal
U.S. Equities137d ago
Regeneron Rises 3.4% on Eye Drug Trial Win; Mobileye Gains on $1.5B Auto Deal
Regeneron's geographic atrophy treatment met primary endpoint in Phase 3 trial while Mobileye landed multi-year European automaker contract